February 20, 2026 · Form 4 insider transaction
LaBrosse Nicole sold 2,876 shares of Halozyme Therapeutics, Inc. at $70.98 per share, a transaction worth $204.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.